glp-1 news october 16 2025 ISPOR 2025: Exploring reasons for discontinuation The Obesity-Drug Revolution Is Stalling
Description
For the CagriSema combination, gastrointestinal adverse events affected 79.6% of participants compared to 39.9% with placebo
An opened Ozempic pen tolerates 56 days at room temperature
Continued use often supports lasting weight control, making Semaglutide GLP-1 an important option for those aiming to manage weight effectively under supervision
Importantly, where irregular menstrual cycles and hyperandrogenism are present, diagnosis is simplified and ultrasound or AMH are not required for diagnosis
Fyrtle offers GLP-1 management as a clinical service through personalized, coordinated care
